NCT01742585View on ClinicalTrials.gov

A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Chronic Kidney DiseaseRenal InsufficiencyHyperphosphatemia
Interventions
DRUG

ASP1585

oral

DRUG

placebo

oral

Trial Locations (5)

Unknown

Chūbu

Hokkaido

Kansai

Kanto

Kyushu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01742585 - A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis | Biotech Hunter | Biotech Hunter